These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10640581)

  • 1. Mathematical modeling of diffusion-mediated release from bulk degrading matrices.
    Tzafriri AR
    J Control Release; 2000 Jan; 63(1-2):69-79. PubMed ID: 10640581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of drug type on the degradation rate of PLGA matrices.
    Siegel SJ; Kahn JB; Metzger K; Winey KI; Werner K; Dan N
    Eur J Pharm Biopharm; 2006 Nov; 64(3):287-93. PubMed ID: 16949804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of the initial stages of drug release from a degradable matrix of poly(d,l-lactide-co-glycolide).
    Frank A; Kumar Rath S; Boey F; Venkatraman S
    Biomaterials; 2004 Feb; 25(5):813-21. PubMed ID: 14609670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and development of a novel controlled release PLGA alginate-pectinate polyspheric drug delivery system.
    Sweet JL; Pillay V; Choonara YE
    Drug Deliv; 2007 Jul; 14(5):309-18. PubMed ID: 17613019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Influence of water-soluble additives on drug release kinetics from biodegradable poly(lactic-co-glycolic acid) matrix].
    Song LP; Yang J; Wang H; Sun HF; Tang LN; Wu L; Chang J; Song CX
    Yao Xue Xue Bao; 2005 Jun; 40(6):557-62. PubMed ID: 16144325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fabrication of multi-layered biodegradable drug delivery device based on micro-structuring of PLGA polymers.
    Ryu WH; Vyakarnam M; Greco RS; Prinz FB; Fasching RJ
    Biomed Microdevices; 2007 Dec; 9(6):845-53. PubMed ID: 17577671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Why degradable polymers undergo surface erosion or bulk erosion.
    von Burkersroda F; Schedl L; Göpferich A
    Biomaterials; 2002 Nov; 23(21):4221-31. PubMed ID: 12194525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling the kinetics of release of octreotide from long-acting formulations injected intramuscularly in rabbits.
    Comets E; Mentré F; Kawai R; Nimmerfall F; Marbach P; Vonderscher J
    J Pharm Sci; 2000 Sep; 89(9):1123-33. PubMed ID: 10944377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mathematical modeling of PLGA microparticles: from polymer degradation to drug release.
    Casalini T; Rossi F; Lazzari S; Perale G; Masi M
    Mol Pharm; 2014 Nov; 11(11):4036-48. PubMed ID: 25230105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The production of uniformly sized polymer microspheres.
    Amsden B
    Pharm Res; 1999 Jul; 16(7):1140-3. PubMed ID: 10450945
    [No Abstract]   [Full Text] [Related]  

  • 11. Conjugation of drug to poly(D,L-lactic-co-glycolic acid) for controlled release from biodegradable microspheres.
    Oh JE; Nam YS; Lee KH; Park TG
    J Control Release; 1999 Feb; 57(3):269-80. PubMed ID: 9895414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chlorhexidine release from an experimental glass ionomer cement.
    Palmer G; Jones FH; Billington RW; Pearson GJ
    Biomaterials; 2004 Oct; 25(23):5423-31. PubMed ID: 15130727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodegradation of PLA/GA polymers: increasing complexity.
    Vert M; Mauduit J; Li S
    Biomaterials; 1994 Dec; 15(15):1209-13. PubMed ID: 7703316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biodegradable nanoparticles containing doxorubicin-PLGA conjugate for sustained release.
    Yoo HS; Oh JE; Lee KH; Park TG
    Pharm Res; 1999 Jul; 16(7):1114-8. PubMed ID: 10450940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the type of release medium on drug release from PLGA-based microparticles: experiment and theory.
    Faisant N; Akiki J; Siepmann F; Benoit JP; Siepmann J
    Int J Pharm; 2006 May; 314(2):189-97. PubMed ID: 16510257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended pulsated drug release from PLGA-based minirods.
    Danyuo Y; E Oberaifo O; Obayemi JD; Dozie-Nwachukwu S; J Ani C; Odusanya OS; Zebaze Kana MG; Malatesta K; Soboyejo WO
    J Mater Sci Mater Med; 2017 Apr; 28(4):61. PubMed ID: 28251469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poly(D,L-lactic-co-glycolic acid) microspheres for sustained delivery and stabilization of camptothecin.
    Ertl B; Platzer P; Wirth M; Gabor F
    J Control Release; 1999 Sep; 61(3):305-17. PubMed ID: 10477803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled release of sirolimus from a multilayered PLGA stent matrix.
    Wang X; Venkatraman SS; Boey FY; Loo JS; Tan LP
    Biomaterials; 2006 Nov; 27(32):5588-95. PubMed ID: 16879865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A temperature-sensitive drug release system based on phase-change materials.
    Choi SW; Zhang Y; Xia Y
    Angew Chem Int Ed Engl; 2010 Oct; 49(43):7904-8. PubMed ID: 20839209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Mechanistic Model for Acidic Drug Release Using Microspheres Made of PLGA 50:50.
    Sevim K; Pan J
    Mol Pharm; 2016 Aug; 13(8):2729-35. PubMed ID: 27398973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.